A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial

BACKGROUND: Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor. The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated. Angiotensin-receptor blockers (ARB) have been the preferential drugs in the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Flávio D, Fuchs, Sandra C, Moreira, Leila B, Gus, Miguel, Nóbrega, Antônio C, Poli-de-Figueiredo, Carlos E, Mion, Décio, Bortolotto, Luiz, Consolim-Colombo, Fernanda, Nobre, Fernando, Coelho, Eduardo Barbosa, Vilela-Martin, José F, Moreno, Heitor, Cesarino, Evandro José, Franco, Roberto, Brandão, Andréa Araujo, de Sousa, Marcos R, Pinho Ribeiro, Antônio Luiz, Jardim, Paulo Cesar, Neto, Abrahão Afiune, Scala, Luiz César N, Mota, Marco, Chaves, Hilton, Alves, João Guilherme, Sobral Filho, Dario C, e Silva, Ricardo Pereira, Figueiredo Neto, José A, Irigoyen, Maria Cláudia, Castro, Iran, Steffens, André Avelino, Schlatter, Rosane, de Mello, Renato Bandeira, Mosele, Francisca, Ghizzoni, Flávia, Berwanger, Otávio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056809/
https://www.ncbi.nlm.nih.gov/pubmed/21349192
http://dx.doi.org/10.1186/1745-6215-12-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056809/
https://www.ncbi.nlm.nih.gov/pubmed/21349192
http://dx.doi.org/10.1186/1745-6215-12-53

Ejemplares similares